Search

Search Results

• 

  New approved drugs for psoriatic arthritis

  F.M. Perrotta, E. Lubrano

  57-64

  09-09-2016

  Published: 9 September 2016

  3026

  PDF: 2168
• 

  Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs

  F.M. Perrotta, O. Addimanda, R. Ramonda, S. D’Angelo, E. Lubrano, A. Marchesoni, I. Olivieri, L. Punzi, C. Salvarani, A. Spadaro

  208-214

  06-11-2014

  Published: 6 November 2014

  2621

  PDF: 1427
• 

  Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs

  E. Lubrano, R. Scarpa

  107-112

  05-06-2012

  Published: 5 June 2012

  1339

  PDF: 1191
• 

  Psoriatic arthritis: imaging techniques

  A. Spadaro, E. Lubrano

  99-106

  05-06-2012

  Published: 5 June 2012

  1838

  PDF: 1742
• 

  Mesenchimal stem cells: a possible role in the pathogenesis and treatment of spondyloarthritis

  F.M. Perrotta, G. Guerra, A. De Socio, S. Scriffignano, E. Lubrano

  1-8

  22-05-2017

  Published: 22 May 2017

  2352

  PDF: 1429
• 

  Assessment of subclinical atherosclerosis in ankylosing spondylitis: correlations with disease activity indices

  F.M. Perrotta, A. Scarno, A. Carboni, V. Bernardo, M. Montepaone, E. Lubrano, A. Spadaro

  105-112

  23-07-2013

  Published: 23 July 2013

  3081

  PDF: 1048
• 

  Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis

  A. Spadaro, A. Scarno, A. Carboni, F.M. Perrotta, C. Catalano, E. Lubrano, G. Valesini

  134-137

  24-07-2013

  Published: 24 July 2013

  2587

  PDF: 709
• 

  Case report of polymyalgia rheumatica in a male patient with three different neoplasms treated with pembrolizumab

  F.M. Perrotta, S. Scriffignano, M. Fatica, M. Specchia, E. Lubrano

  178-181

  19-11-2020

  Published: 19 November 2020

  1150

  PDF: 692
• 

  In memory of Dr. Luis Espinoza

  R. Scarpa, A. Cauli, E. Lubrano

  124

  23-07-2020

  Published: 23 July 2020

  689

  PDF: 447
• 

  Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study

  F.M. Perrotta, A. Delle Sedie, S. Scriffignano, P. Volpe, E. Cordisco, N. Milano, M. Gabini, E. Lubrano

  52-59

  10-04-2020

  Published: 10 April 2020

  1871

  PDF: 1056
• 

  Occult axial involvement in patients with psoriatic arthritis mutilans: a case report

  F.M. Perrotta, S. Scriffignano, A. De Socio, E. Lubrano

  88-91

  09-07-2019

  Published: 9 July 2019

  1886

  PDF: 891

• The holistic management of peripheral spondyloarthritis: focus on articular involvement in patients with inflammatory bowel disease

  Ennio Lubrano, Alessandro Armuzzi, Silvia Scriffignano, Carla Felice, Fabio Massimo Perrotta, Vincenzo Venerito, Sergio Del Vescovo, Roberta Ramonda, Giulia Cassone, Fabiola Atzeni, Roberto Caporali, Fabrizio Conti, Elisa Gremese, Florenzo Iannone, Marco Sebastiani, Ennio Giulio Favalli

  11-11-2024

  Published: 11 November 2024

  946

  PDF: 39

• From rehabilitation to remission in ankylosing spondylitis

  E. Lubrano, A. Spadaro

  241-243

  Published:

  1034

  PDF: 676

• Visceral muscle dysmotility syndrome in systemic lupus erythematosus: which is the role of 18 fluorodeoxyglucose-positron emission tomography-computed tomography? A clinical case and literature review

  S. Scriffignano, F.M. Perrotta, M. Ricci, B. Carabellese, E. Lubrano

  24-09-2024

  Published: 24 September 2024

  599

  PDF: 105

• Complementary medicine in rheumatoid arthritis

  P. Sarzi- Puttini, F. Atzeni, E. Lubrano

  226-231

  Published:

  2179

  PDF: 1874